CDK5 and Alzheimer disease: Although we did not observe changes in t‐tau or p‐tau with CAPN2 inhibitors (Figure 6A and 6B), similar to the reported mechanism for SYK, an indirect link has been proposed connecting CAPN2 protein activation and tau phosphorylation in AD via CDK5 activation.37